Rationale Airway remodelling (AR) contributes to airflow limitation and poor symptom control in severe asthma. While anti-IL-5 therapy improves clinical outcomes in severe asthma, the cellular and molecular mechanisms underlying its effects on AR remain incompletely understood. Objectives.
IL-5 blockade restores the bronchial epithelium and attenuates airway remodelling in severe asthma
calendar_today
July 24, 2026
person
Zanin, O., Eminton, A. J., Freydina, D., Kanabar, V., Drummond, I., Horton, K., Phillips, J., Dhillon, R., Naftel, J., Soe, W., Dennison, P., Lau, L., Ward, J., Blume, C., Swindle, E. J., Martinez-Nunez, R. T., Rupani, H.
domain
medrxiv